M
Q. . . . . . . . . is a carrier-mediated process.
- Correct Answer - Option(B)
- Views: 837
- Filed under category Pharmacology and Toxicology
Share
Loading comments.....
Related Posts
Q. The antidote BAL is used to reduce toxicity of
Q. Gatifloxacin has been withdrawn from market becuase.
Q. . . . . . . . . is a carrier-mediated process.
Q. Which one of the following group is responsible for the duration of the local anesthetic action?
Q. The half life of insulin of normal subject . . . . . . . . minute
View All Posts
Question analytics

Discusssion
Login to discuss.